Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36801 clinical trials
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Treatment options for older adults with Acute Myeloid Leukaemia (AML) and Myelodysplasia (MDS) are limited. Although stem cell transplantation remains one of the most effective treatments it is associated with severe side effects which have until recently prevented its use in older adults. In the last decade the use of …

recurrent disease
leukemia
pulmonary function test
blood count
thiotepa
  • 0 views
  • 16 Feb, 2024
  • 1 location
Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia

Background. Cancer is the leading cause of death by disease in children. Most pediatric tumors differ from adult tumors in terms of biological and clinical characteristics.

cancer
pediatric
  • 0 views
  • 05 Aug, 2020
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Localized Renal Tumor

Hyperpolarized 13C pyruvate MRI may help doctors determine non-invasively whether a kidney tumor is a benign tumor or cancer, and if cancer, how aggressive it is. This may help doctors and patients with renal tumors in the future to make better treatment decisions.

MRI
abdominal mri
estimated creatinine clearance
hyperpolarized carbon c 13 pyruvate
nephrectomy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Psychotherapy (Accelerated Resolution Therapy) for Cancer Related Trauma and Distress

This study may provide evidence to support integration of accelerated resolution therapy into psychological treatment of cancer patients, which may decrease cancer related trauma and distress.

bone marrow transplant
metastasis
solid neoplasm
bone marrow procedure
traumatic stress disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location
  • 0 views
  • 17 Apr, 2023
  • 3 locations
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts.

biomarker analysis
metastatic melanoma
monoclonal antibodies
immune checkpoint inhibitor
hepatitis
  • 0 views
  • 16 Feb, 2024
  • 9 locations
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule

This is a study to evaluate the tolerance, dose-limiting toxicity (DLT), phase II recommended dose (RP2D), and maximum tolerated dose (MTD) of single and multiple oral doses of TQB3474 in patients with advanced malignant tumors.

cancer
multiple myeloma
refractory multiple myeloma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

This phase II trial studies how well decitabine with ruxolitinib or fedratinib works before hematopoietic stem cell transplant in treating patients with accelerated/blast phase myeloproliferative neoplasms (tumors). Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, …

myeloproliferative/myelodysplastic disorders
blast crisis
leukemia
chronic myeloproliferative disease
decitabine
  • 0 views
  • 16 Feb, 2024
  • 1 location
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

prostatic neoplasms, castration-resistant
measurable disease
combination therapy
combined modality therapy
antiandrogens
  • 0 views
  • 16 Feb, 2024
  • 22 locations
Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

PEGASUS is a prospective multi-centric study designed to prove the feasibility of using liquid biopsy to guide the post-surgical and post-adjuvant clinical management in 140 microsatellite stable Stage-III and T4N0 Stage-II colon cancer patients.

colon cancer
adjuvant
stage ii colon cancer
folfiri regimen
capecitabine
  • 0 views
  • 16 Feb, 2024
  • 9 locations